Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance
Fifty 1 Labs (OTCPK: FITY), formerly Consumer Automotive Finance (OTCPK: CAFI), has completed its name and ticker symbol change with FINRA, now trading as FITY on the OTC market. The company, operating in the sports supplement, fitness equipment, and health and wellness sectors, has submitted responses to a second round of comments in its effort to regain SEC Rule 15c2-11 compliance.
The company has rescheduled its teleconference to March 17th, 2025, where management will discuss strategic direction and provide updates. CEO Brandon Spikes emphasized the importance of the name change in strengthening their market position and highlighted that regaining 15c2-11 compliance remains a priority for improving shareholder transparency and liquidity.
Fifty 1 Labs (OTCPK: FITY), precedentemente conosciuta come Consumer Automotive Finance (OTCPK: CAFI), ha completato il cambio di nome e simbolo di ticker con la FINRA, ora scambiando come FITY nel mercato OTC. L'azienda, che opera nei settori degli integratori sportivi, attrezzature per il fitness e salute e benessere, ha presentato risposte a un secondo giro di commenti nel suo sforzo di ripristinare la conformità alla Regola SEC 15c2-11.
L'azienda ha riprogrammato la sua teleconferenza per il 17 marzo 2025, durante la quale la direzione discuterà la direzione strategica e fornirà aggiornamenti. Il CEO Brandon Spikes ha sottolineato l'importanza del cambio di nome nel rafforzare la loro posizione di mercato e ha evidenziato che ripristinare la conformità alla 15c2-11 rimane una priorità per migliorare la trasparenza e la liquidità per gli azionisti.
Fifty 1 Labs (OTCPK: FITY), anteriormente conocido como Consumer Automotive Finance (OTCPK: CAFI), ha completado el cambio de nombre y símbolo de ticker con FINRA, ahora cotizando como FITY en el mercado OTC. La compañía, que opera en los sectores de suplementos deportivos, equipos de fitness y salud y bienestar, ha presentado respuestas a una segunda ronda de comentarios en su esfuerzo por recuperar la conformidad con la Regla SEC 15c2-11.
La compañía ha reprogramado su teleconferencia para el 17 de marzo de 2025, donde la dirección discutirá la dirección estratégica y proporcionará actualizaciones. El CEO Brandon Spikes enfatizó la importancia del cambio de nombre para fortalecer su posición en el mercado y destacó que recuperar la conformidad con la 15c2-11 sigue siendo una prioridad para mejorar la transparencia y liquidez para los accionistas.
Fifty 1 Labs (OTCPK: FITY), 이전에는 Consumer Automotive Finance (OTCPK: CAFI)로 알려졌던 이 회사는 FINRA와의 이름 및 티커 기호 변경을 완료하고 현재 OTC 시장에서 FITY로 거래되고 있습니다. 이 회사는 스포츠 보충제, 피트니스 장비 및 건강 및 웰빙 분야에서 활동하고 있으며, SEC 규정 15c2-11 준수를 회복하기 위한 노력의 일환으로 두 번째 댓글에 대한 답변을 제출했습니다.
회사는 2025년 3월 17일에 예정된 전화 회의를 재조정했으며, 이 회의에서 경영진은 전략적 방향에 대해 논의하고 업데이트를 제공할 것입니다. CEO Brandon Spikes는 이름 변경이 시장 위치를 강화하는 데 중요하다고 강조하며, 15c2-11 준수를 회복하는 것이 주주 투명성과 유동성을 개선하기 위한 우선 사항임을 강조했습니다.
Fifty 1 Labs (OTCPK: FITY), anciennement connu sous le nom de Consumer Automotive Finance (OTCPK: CAFI), a terminé le changement de son nom et de son symbole de ticker auprès de la FINRA, et se négocie désormais sous le nom de FITY sur le marché OTC. L'entreprise, qui opère dans les secteurs des compléments alimentaires pour le sport, des équipements de fitness et de la santé et du bien-être, a soumis des réponses à un second tour de commentaires dans son effort pour retrouver la conformité à la règle SEC 15c2-11.
L'entreprise a reprogrammé sa téléconférence pour le 17 mars 2025, où la direction discutera de l'orientation stratégique et fournira des mises à jour. Le PDG Brandon Spikes a souligné l'importance du changement de nom pour renforcer leur position sur le marché et a souligné que retrouver la conformité à la 15c2-11 reste une priorité pour améliorer la transparence et la liquidité des actionnaires.
Fifty 1 Labs (OTCPK: FITY), früher bekannt als Consumer Automotive Finance (OTCPK: CAFI), hat die Änderung seines Namens und seines Tickersymbols bei der FINRA abgeschlossen und wird nun als FITY am OTC-Markt gehandelt. Das Unternehmen, das in den Bereichen Sportnahrung, Fitnessgeräte und Gesundheit und Wellness tätig ist, hat auf eine zweite Runde von Kommentaren reagiert, um die Einhaltung der SEC-Regel 15c2-11 wiederherzustellen.
Das Unternehmen hat seine Telefonkonferenz auf den 17. März 2025 neu angesetzt, in der die Geschäftsführung die strategische Ausrichtung besprechen und Updates bereitstellen wird. CEO Brandon Spikes betonte die Bedeutung der Namensänderung zur Stärkung ihrer Marktposition und hob hervor, dass die Wiederherstellung der 15c2-11-Einhaltung eine Priorität bleibt, um die Transparenz und Liquidität für die Aktionäre zu verbessern.
- Successful completion of name and ticker symbol change with FINRA
- Progress toward regaining 15c2-11 compliance with second round of comments submitted
- Currently non-compliant with SEC Rule 15c2-11, affecting market transparency and liquidity
MELBOURNE, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTCPK: FITY), formerly Consumer Automotive Finance, Inc. (OTCPK: CAFI), a dynamic leader in the sports supplement, fitness equipment, and health and wellness sectors, is pleased to announce the successful completion of its name and ticker symbol change with the Financial Industry Regulatory Authority (FINRA). The company is now officially trading under the ticker symbol FITY on the OTC market tier. This marks a significant milestone as Fifty 1 Labs continues executing its strategic growth initiatives.
In addition to the name and symbol change, the company has responded to a second round of comments in its ongoing efforts to regain compliance with SEC Rule 15c2-11. Restoring this status is a critical step that will enhance market transparency and ensure greater accessibility for investors.
With these recent developments, Fifty 1 Labs has rescheduled its previously announced teleconference to Monday, March 17th, 2025. During the call, company leadership will outline its strategic direction, provide key updates, and address shareholder questions. Details regarding the time and access instructions for the teleconference will be provided in a forthcoming announcement.
"We are excited about the progress we've made in solidifying our brand identity and strengthening our market position," said Brandon Spikes, CEO of Fifty 1 Labs. "Finalizing our name and symbol change represents an important step forward as we continue executing on our long-term vision. Additionally, regaining our 15c2-11 compliance remains a top priority, as it is essential for providing greater transparency and liquidity for our shareholders."
Fifty 1 Labs remains committed to delivering innovative solutions across the sports supplement, fitness equipment, and health and wellness markets. The company will continue updating shareholders as it advances its growth strategy and achieves new milestones.
About Fifty 1 Labs, Inc.
Fifty 1 Labs, Inc. (OTCPK: FITY) is a leading innovator in the sports supplement, fitness equipment, and health and wellness industries. The company is focused on delivering high-quality products designed to enhance performance, well-being, and overall lifestyle. With a strategic vision for growth. The company operates four key subsidiaries: 51, LLC, which specializes in sports supplements; The Quickness, which offers patented athletic training equipment; Astound NMN, a leader in anti-aging and DNA repair supplements; and Drago Knives, patented knife throwing technology. Fifty 1 Labs, Inc. is also actively pursuing strategic acquisitions to expand its portfolio and drive sustainable growth.
Safe Harbor Statement:
The information provided in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Identifiable by words such as "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions, these statements may also be made in written or oral form in the company's filings with the U.S. Securities and Exchange Commission, OTC Markets, press releases, other written materials, or in oral statements made by its officers, directors, or employees to third parties. There can be no assurance that such statements will prove to be accurate. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company's Disclosure Statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the company's control. The company does not undertake any obligation to update publicly or to revise any statements in this release, whether as a result of new information, future events, or otherwise.
Investor Relations Contact:
Investor Relations
877-814-4188
ir@fifty1labs.com
FAQ
What is the significance of Fifty 1 Labs (FITY) regaining 15c2-11 compliance?
When will Fifty 1 Labs (FITY) hold its rescheduled teleconference?
What was Fifty 1 Labs' (FITY) previous company name and ticker symbol?
What markets does Fifty 1 Labs (FITY) operate in?
